Published in Br Med J on March 01, 1969
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ (2004) 21.39
Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc (1998) 6.21
Predisposing factors in adverse reactions to drugs. Br Med J (1969) 5.80
Relation between physician characteristics and prescribing for elderly people in New Brunswick. CMAJ (1994) 5.32
Towards the safer use of medicines. BMJ (1995) 3.50
Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One (2009) 3.45
Iatrogenic disease in general practice: its incidence and effects. Br Med J (1973) 3.27
Methodology and rationale for the measurement of harm with trigger tools. Qual Saf Health Care (2003) 2.44
Plasma digoxin concentration--its relation to digoxin dosage and clinical effects in patients with atrial fibrillation. Br Heart J (1972) 2.28
Physician characteristics and prescribing for elderly people in New Brunswick: relation to patient outcomes. CMAJ (1995) 2.25
Admissions to hospital due to drugs. Br Med J (1969) 2.17
Adverse reactions to drugs in general practice. Br Med J (1979) 2.02
Prospective study of drug reporting by general practitioners for an elderly population referred to a geriatric service. Br Med J (Clin Res Ed) (1987) 2.02
Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol (1999) 1.97
Prescribing in Northern Ireland. Study No. 2: systematic anti-infectives. Ulster Med J (1978) 1.70
Detection of drug-induced disease. Br J Clin Pharmacol (1979) 1.56
Large-scale digitoxin intoxication. Br Med J (1970) 1.54
Patterns of medical drug use - a community focus. Can Med Assoc J (1976) 1.47
Errors of drug prescribing. Br J Clin Pharmacol (1975) 1.45
The prevention of adverse drug reactions--a potential role for pharmacists in the primary care team? J R Coll Gen Pract (1981) 1.39
Drug-induced blood dyscrasias in Sweden. Br Med J (1973) 1.30
Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag (2005) 1.29
Incidence of adverse drug events and medication errors in Japan: the JADE study. J Gen Intern Med (2010) 1.21
Digitalis: where are we now? Br Heart J (1985) 1.11
Comparison of two recently published algorithms for assessing the probability of adverse drug reactions. Br J Clin Pharmacol (1982) 1.00
Use of hypnotic medicines by elderly people in residential homes. J R Coll Gen Pract (1988) 0.99
A pharmacovigilance study in the department of medicine of a university teaching hospital. Pharm Pract (Granada) (2007) 0.95
Interactions with digoxin: more problems. Br Med J (Clin Res Ed) (1982) 0.91
Difficulties in assessing the adverse effects of drugs. Br J Clin Pharmacol (1981) 0.90
Adverse biochemical and clinical consequences of furosemide administration. Can Med Assoc J (1978) 0.89
Digitalis intoxication: a new approach to an old problem. Br Med J (Clin Res Ed) (1983) 0.89
Adverse reactions in patients with rheumatic diseases. Retrospective analysis of causes of admission and out-patient attendance in a specialist centre. Ann Rheum Dis (1973) 0.88
A pharmacovigilance study in medicine department of tertiary care hospital in chhattisgarh (jagdalpur), India. J Young Pharm (2010) 0.86
Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study. Br J Clin Pharmacol (1993) 0.86
Clinical implications of changes in hepatic drug metabolism in older people. Ther Clin Risk Manag (2005) 0.86
Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital. J Pharmacol Pharmacother (2012) 0.85
Adverse effects of clozapine. Psychopharmacology (Berl) (1989) 0.81
Clinical pharmacology. Drugs in children. Br Med J (Clin Res Ed) (1981) 0.78
Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010. Int J Neuropsychopharmacol (2014) 0.78
Risk Factors Associated with the Requirement for Pharmaceutical Intervention in the Hospital Setting: A Systematic Review of the Literature. Drugs Real World Outcomes (2016) 0.77
The incidence of adverse reactions to drugs. J Clin Pathol Suppl (R Coll Pathol) (1975) 0.75
Adverse drug reactions. Br Med J (Clin Res Ed) (1981) 0.75
Measuring digoxin. Br Med J (1970) 0.75
Adverse reactions to nitrofurantoin in relation to cellular and humoral immune responses. Clin Exp Immunol (1977) 0.75
The changing pattern of toxicity of digoxin. Postgrad Med J (1981) 0.75
Reliability of adverse drug reaction assessment in psychiatric inpatients. Eur Arch Psychiatry Neurol Sci (1985) 0.75
Drug interactions and lethal drug combinations. J Clin Pathol Suppl (R Coll Pathol) (1975) 0.75
Clinical pharmacology as a specialty. Br Med J (1969) 0.75
The use of digoxin in 55 residential homes for elderly people. Postgrad Med J (1988) 0.75
Diuretics. I--Benzothiadiazines and related drugs. Br Med J (1969) 0.75
Use of digitalis in general practice. Liverpool Therapeutics Group. Br Med J (1978) 0.75
New strategies for drug monitoring. Br Med J (1977) 0.75
Digoxin measurements in general practice. Br J Clin Pharmacol (1977) 0.75
Adverse reactions to medication on a coronary care unit. Postgrad Med J (1979) 0.75
Adverse reactions to psychotropic drugs. J R Coll Gen Pract (1973) 0.75
Ampicillin and urticaria. Br Med J (1969) 0.75
A selected public health bibliography with annotations. Am J Public Health Nations Health (1969) 0.75
Polypharmacy in the Elderly: Drug reactions and interaction in the aged. Can Fam Physician (1991) 0.75
Drug-Induced Liver Injury during Antidepressant Treatment: Results of AMSP, a Drug Surveillance Program. Int J Neuropsychopharmacol (2016) 0.75
Monitoring adverse reactions to antibiotics in general practice. J Epidemiol Community Health (1982) 0.75
Editorial: Care in prescribing. Br Med J (1976) 0.75
Potassium in heart failure. Br Med J (1977) 0.75
Excipients, adverse drug reactions and patients' rights. CMAJ (1994) 0.75
THE HAZARDS OF HOSPITALIZATION. Ann Intern Med (1964) 8.48
STUDIES ON THE EPIDEMIOLOGY OF ADVERSE DRUG REACTIONS. I. METHODS OF SURVEILLANCE. JAMA (1964) 5.92
Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility. Ann Intern Med (1966) 5.11
Adverse reactions during hospitalization. Can Med Assoc J (1967) 3.96
COMPARISON OF AMPICILLIN AND CHLORAMPHENICOL IN TREATMENT OF PARATYPHOID FEVER. Br Med J (1964) 3.67
Drug reactions and errors in administration on a medical ward. Can Med Assoc J (1967) 3.00
AMPICILLIN IN TREATMENT OF CERTAIN GRAM-NEGATIVE BACTERIAL INFECTIONS. Br Med J (1963) 2.72
Drug surveillance utilizing nurse monitors. An epidemiological approach. Lancet (1966) 2.69
Evaluation of a method of prescribing drugs in hospital, and a new method of recording their administration. Lancet (1967) 2.30
EPIDEMIOLOGICAL STUDIES OF ADVERSE DRUG REACTIONS. Am J Public Health Nations Health (1965) 2.04
Clinical and laboratory aspects of drug allergy. Proc R Soc Med (1968) 1.62
Symposium on drug sensitization. General introduction. Proc R Soc Med (1962) 1.54
Adverse drug reactions during hospitalization. Can Med Assoc J (1968) 1.45
A hospital adverse drug reaction reporting program. Hospitals (1966) 1.42
Adverse drug reactions without drugs. Lancet (1967) 1.42
Predisposing factors in adverse reactions to drugs. Br Med J (1969) 5.80
An analysis of prescribing of an hypnotic in the community. Br J Prev Soc Med (1972) 4.05
Medical audits. J R Coll Physicians Lond (1980) 3.15
Prescribing of chloramphenicol and aplastic anaemia. J Coll Gen Pract (1966) 2.93
Admissions to hospital due to drugs. Br Med J (1969) 2.17
Relationship between exposure to asbestos and pleural malignancy in Belfast. Ann N Y Acad Sci (1965) 1.81
Prescribing of drugs reported to cause adverse reactions. Br J Prev Soc Med (1972) 1.67
Prescribing in Northern Ireland. Methods of analysis. Ulster Med J (1976) 1.56
Drug therapy in the elderly. Age Ageing (1972) 1.52
Value of ampicillin in the hospital treatment of exacerbations of chronic bronchitis. Br Med J (1965) 1.51
Following advice in general practice. J R Coll Gen Pract (1976) 1.39
The measurement of drug consumption. Drugs for diabetes in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol (1975) 1.30
Prescribing in Northern Ireland. Study no. 1: Sleeping tablets. Ulster Med J (1976) 1.26
The prescribing of drugs used in the treatment of diabetes. Br J Prev Soc Med (1973) 1.19
British National Formulary: its birth, death, and rebirth. BMJ (1993) 1.12
Pattern of drug-induced disease in the community. An unsolved enigma. Br Med Bull (1970) 1.02
Diagnosis and treatment of intravascular lymphomatosis. Arch Neurol (2000) 1.02
Tolerance to sympathomimetic bronchodilators in guinea-pig isolated lungs following chronic administration in vivo. Br J Pharmacol (1975) 0.97
Monitoring adverse reactions to drugs: toward a therapeutic audit. Int J Health Serv (1974) 0.91
Pathogenic organisms in the sputum of patients with chronic bronchitis. Thorax (1967) 0.89
Telepathology on the Solomon Islands--two years' experience with a hybrid Web- and email-based telepathology system. J Telemed Telecare (2004) 0.88
Cytomegalovirus-infected cells in a pleural effusion from an acquired immunodeficiency syndrome patient. A case report. Acta Cytol (1994) 0.85
Primary amyloidosis with unusual bone involvement: reversibility with melphalan, prednisone, and colchicine. Am J Med (1989) 0.84
William Withering and digitalis, 1785 to 1985. Br Med J (Clin Res Ed) (1985) 0.83
Epstein-Barr virus subtype distribution in angioimmunoblastic lymphadenopathy. Int J Cancer (1993) 0.83
Prescribing and the british national formulary. Br Med J (1966) 0.82
Soft tissue response to textured silicone implants in an animal experiment. Plast Reconstr Surg (1993) 0.81
A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma. Leukemia (1995) 0.81
Significant or important? Br J Clin Pharmacol (1977) 0.81
Digoxin 1785-1985. I. Two hundred years of digitalis. J Clin Hosp Pharm (1986) 0.81
The legacy of Richard Burdon Haldane: the university clinical units and their future. Ulster Med J (1976) 0.79
Carcinocythemia. Report of two cases, one simulating a Burkitt lymphoma. Acta Cytol (1990) 0.79
Tolerance to sympathomimetic bronchodilators in the guinea pig lungs. Br J Pharmacol (1975) 0.79
Chronic overexpression of membrane-bound flt3 ligand by T lymphocytes in severe aplastic anaemia. Br J Haematol (2000) 0.79
Prenatal diagnosis of severe congenital malformations associated with elevated amniotic fluid alpha-feto protein. Clin Genet (1979) 0.78
Immunotactoid-like glomerulopathy with massive fibrillary deposits in liver and bone marrow in monoclonal gammopathy. Am J Nephrol (1996) 0.78
Emphysema in pathogen-free and bronchitic rats: an electronic lung-scanning technique. Am Rev Respir Dis (1974) 0.77
Late appearance of thrombotic thrombocytopenic purpura after autoimmune hemolytic anemia and in the course of chronic autoimmune thrombocytopenic purpura: two case reports. Acta Haematol (1991) 0.77
Candidemia and sternal Candida albicans osteomyelitis in a patient with chronic lymphatic leukemia. Isr J Med Sci (1984) 0.76
Complex IgA gammopathy in Gaucher's disease. Leuk Lymphoma (1995) 0.76
Alterations on the 5' noncoding region of the BCL-6 gene are not correlated with BCL-6 protein expression in T cell non-Hodgkin lymphomas. Lab Invest (2001) 0.76
Progressive cutaneous herpes simplex infection in acute myeloblastic leukemia. Successful treatment with interferon and cytarabine. Arch Dermatol (1984) 0.76
The war on drugs. Legalisation may be necessary. BMJ (1996) 0.75
Adverse reactions to psychotropic drugs. J R Coll Gen Pract (1973) 0.75
Splenic rupture as a presenting sign of lymphoma of the spleen. Isr J Med Sci (1984) 0.75
Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disorders. Blood (1995) 0.75
The incidence of adverse reactions to drugs. J Clin Pathol Suppl (R Coll Pathol) (1975) 0.75
Enhanced urinary trypsin inhibitory activity in gentamicin-induced nephrotoxicity in rats. Clin Chim Acta (1988) 0.75
[gamma-heavy chain production as an epiphenomenon in non-Hodgkin's lymphoma]. Dtsch Med Wochenschr (1994) 0.75
Neonatal neurofibromatosis: unusual manifestations with malignant clinical course. Clin Genet (1975) 0.75
Extranodal multilobated B-cell lymphoma: diagnosis by fine needle aspiration. Cytopathology (1992) 0.75
The hazards of drugs. J Ir Med Assoc (1965) 0.75
The amniotic band syndrome. Obstet Gynecol (1973) 0.75
Drug utilization studies: implications for medical care. Plenary lecture. Acta Med Scand Suppl (1984) 0.75
Monitoring the adverse reactions to drugs and the discipline of therapeutic auditing. Q J Med (1971) 0.75
Clinical and pathological features of non-Hodgkin's lymphoma of the tonsil. Review of the literature and report of 10 cases. Isr J Med Sci (1989) 0.75
Massive atheromatous emboli to both kidneys: a fatal complication following aortic surgery. J Cardiovasc Surg (Torino) (1988) 0.75
Influence of exogenous protease inhibitor (Bowmann-Birk inhibitor) in gentamicin-induced nephrotoxicity in rats. Contrib Nephrol (1990) 0.75
Immunological challenge with virus initiates leukotriene C4 production in the heart and induces cardiomyolysis in guinea pigs. Prostaglandins Leukot Med (1986) 0.75
[Thanatophoric dwarfism: of 2 families]. Harefuah (1972) 0.75
[Clinical evaluation of Madinon-s, an oral contraceptive]. Harefuah (1970) 0.75
Antivivisection. Br Med J (Clin Res Ed) (1983) 0.75
Decreased Cellularity and Hemosiderin of the Bone Marrow in Healthy and Overtrained Competitive Distance Runners. Phys Sportsmed (1986) 0.75
Evans' syndrome in Castleman's disease: unusual presentation with rectal bleeding from angiodysplasia of cecum. Isr J Med Sci (1992) 0.75
Pulmonary alveolar proteinosis associated with recurrence of Hodgkin's disease in the lung. Isr J Med Sci (1990) 0.75
Kaposi's sarcoma in two lymphoma patients with hepatitis B and other infections. Cancer (1984) 0.75
Tubular confronting cisternae in hairy cells following interferon therapy. Ann Oncol (1990) 0.75
The geography of the use of thyroid and antithyroid drugs in Northern Ireland (preliminary report). Proc R Soc Med (1968) 0.75
The Committee on Review of Medicines. J Clin Hosp Pharm (1985) 0.75